Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2011 | Letter to the Editor

Suggested randomised, controlled trial with frovatriptan

Authors: Peer Tfelt-Hansen, Timothy J. Steiner

Published in: The Journal of Headache and Pain | Issue 6/2011

Excerpt

Sir, …

Tullo V, Allais G, Ferrari MD, Curone M, Mea E, Omboni S, Benedetto C, Zava D, Bussone G (2010) Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci 31(Suppl 1):S51–S54 10.1007/s10072-010-0273-xPubMedCrossRef

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain 12:219–226 10.1007/s10194-010-0243-y, 1:CAS:528:DC%2BC3MXksVCgu70%3DPubMedCentralPubMedCrossRef

Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 12:361–368 10.1007/s10194-011-0325-5, 1:CAS:528:DC%2BC3MXmtFSmsb8%3DPubMedCentralPubMedCrossRef

International Headache Society Clinical Trials Subcommittee (2000). Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 20:765–786

Cortelli P, Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci 32(Suppl 1):S95–S98 10.1007/s10072-011-0551-2PubMedCrossRef

Lampl C, Voelker M, Diener HC (2007) Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol 254:705–712 10.1007/s00415-007-0547-2, 1:CAS:528:DC%2BD2sXovFait7w%3DPubMedCrossRef

World Health Organization (2010) WHO model list of essential medicines, 16th list. WHO, Geneva. http://www.who.int/medicines/publications/essentialmedicines/Updated_sixteenth_adult_list_en.pdf

Title: Suggested randomised, controlled trial with frovatriptan
Authors: Peer Tfelt-Hansen
Timothy J. Steiner
Publication date: 01-12-2011
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 6/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-011-0381-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Suggested randomised, controlled trial with frovatriptan

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

Familial occipital neuralgia with sporadic nervus intermedius neuralgia (NIN)

Chronic migraine classification: current knowledge and future perspectives

Jean Schoenen, David W. Dodick, Peter S. Sándor: Comorbidity in Migraine

Clinical features of headache patients with fibromyalgia comorbidity

Variants in the human potassium channel gene (KCNN3) are associated with migraine in a high risk genetic isolate

Service use and costs for people with headache: a UK primary care study